Gene expression profiles in human gastric cancer: Expression of maspin correlates with lymph node metastasis

British Journal of Cancer

Volumn 92, Issue 6, 2005, Pages 1130-1136

  Terashima, M ^a   Maesawa, C ^b   Oyama, K ^b   Ohtani, S ^a   Akiyama, Y ^b   Ogasawara, S ^b   Takagane, A ^b   Saito, K ^b   Masuda, T ^b   Kanzaki, N ^a   Matsuyama, S ^a   Hoshino, Y ^a   Kogure, M ^a   Gotoh, M ^a   Shirane, M ^c   Mori, K ^c  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Gastric cancer; Gene expression profiles; Maspin; Oligonucleotide microarray

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MASPIN; SERINE PROTEINASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH EPITHELIUM; TUMOR GROWTH; ADULT; AGED; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); SERPINS; STOMACH NEOPLASMS;

EID: 20244385294     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602429     Document Type: Article

References (31)

1. Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T (2003) Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163: 1911-1919
2. Arias AM (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105: 425-431
3. Domann FE, Rice JC, Hendrix MJ, Futscher BW (2000) Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85: 805-810
4. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868
5. Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, Katagiri T, Tsunoda T, Yamaoka Y, Nakamura Y (2002) Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62: 7012-7017
6. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, Rickert P (2002) Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21: 7749-7763
7. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukayama M, Kodama T, Aburatani H (2002) Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62: 233-240
8. Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M (2002) Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res 8: 3475-3479
9. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1: 10-24
10. Kim DY, Kim HR, Shim JH, Park CS, Kim SK, Kim YJ (2000) Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J Surg Oncol 74: 185-192
11. Kim S, Han J, Kim J, Park C (2004) Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 64: 6900-6905
12. Kinugasa T, Kuroki M, Takeo H, Matsuo Y, Ohshima K, Yamashita Y, Shirakusa T, Matsuoka Y (1998) Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas. Int J Cancer 76: 148-153
13. Kodera Y, Isobe K, Yamauchi M, Satta T, Hasegawa T, Oikawa S, Kondoh K, Akiyama S, Itoh K, Nakashima I (1993) Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation. Br J Cancer 68: 130-136
14. Kojima O, Ikeda E, Uehara Y, Majima T, Fujita Y, Majima S (1984) Correlation between carcinoembryonic antigen in gastric cancer tissue and survival of patients with gastric cancer. Gann 75: 230-236
15. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ (1999) High density synthetic oligonucleotide arrays. Nat Genet 21: 20-24
16. Maass N, Biallek M, Rosel F, Schem C, Ohike N, Zhang M, Jonat W, Nagasaki K (2002) Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 297: 125-128
17. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W, Nagasaki K (2001) Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817
18. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, Hioki K (1994) Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 73: 2703-2708
19. Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29
20. Roukos DH (2000) Current status and future perspectives in gastric cancer management. Cancer Treat Rev 26: 243-552
21. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ (1998) Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58: 5681-5685
22. Sheng S, Pemberton PA, Sager R (1994) Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 269: 30988-30993
23. Son HJ, Sohn TS, Song SY, Lee JH, Rhee JC (2002) Maspin expression in human gastric adenocarcinoma. Pathol Int 52: 508-513
24. Song SY, Lee SK, Kim DH, Son HJ, Kim HJ, Lim YJ, Lee WY, Chun HK, Rhee JC (2002) Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig Dis Sci 47: 1831-1835
25. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJ (2002) The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-2932
26. Tamura G (2002) Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol Histopathol 17: 323-329
27. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573
28. Umekita Y, Hiipakka RA, Liao S (1997) Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Lett 113: 87-93
29. Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng S, El-Naggar A, Hung MC (2000) High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19: 2398-2403
30. Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H (2001) Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 4: 113-121
31. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529